Dna Group (T.R.) Ltd (TLV:DNA)
Israel
· Delayed Price · Currency is ILS · Price in ILA 98.70
+1.40 (1.44%)
Apr 1, 2025, 3:43 PM IDT
Dna Group (T.R.) Market Cap
Dna Group (T.R.) has a market cap or net worth of 119.84 million as of April 1, 2025. Its market cap has increased by 13.67% in one year.
Market Cap
119.84M
Enterprise Value
51.53M
Revenue
306.00K
Ranking
n/a
PE Ratio
5.44
Stock Price
98.70
Market Cap Chart
Since December 3, 2007, Dna Group (T.R.)'s market cap has increased from 31.81M to 119.84M, an increase of 276.70%. That is a compound annual growth rate of 7.95%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 65.58B |
| Danel (Adir Yeoshua) | 2.20B |
| Kamada | 1.41B |
| Bait Bakfar | 960.19M |
| Novolog (Pharm-Up 1966) | 813.77M |
| Ilex Medical | 700.98M |
| BrainsWay | 637.11M |
| SofWave Medical | 548.02M |